undamentalytics Newsletter

Lantheus Holdings, Inc. balance sheet

At the end of fiscal 2025, Lantheus Holdings, Inc. had total assets of $2.23bn, total liabilities of $1.14bn and shareholders' equity of $1.09bn. It held $359m in cash against $569m of debt: net debt of $210m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Lantheus Holdings, Inc.: balance sheet, annual
Fiscal year2013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents1920295176113938099416714913359593
Receivables—4237374044445489213284321359353
Inventory—16161826332936353564686558
Total current assets—81901111481951731842366781,0861,3279001,027
Goodwill—1616161616165961616161240239
Total assets—2432422563844404068708641,3211,6511,9802,2272,415
Accounts payable—16121917181916212141354348
Total current liabilities—4936444753668190248187241333336
Short-term debt——443310211201111
Long-term debt—393350274265264184198163558562565569570
Total debt0401354278268266195218175575575566569571
Total liabilities—4824283623613692913563998748358921,1381,103
Shareholders' equity−236−239−185−10723711155144644478161,0881,0901,312
Net debt (negative = net cash)−1938132522719215310213976159−139−347210−22
Shares outstanding—18m30m38m38m39m39m67m68m69m70m68m65m65m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: LNTH vs PAHCINDV vs LNTHLNTH vs TRLV

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Lantheus Holdings, Inc.'s SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Lantheus Holdings, Inc.